Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

A gradual decay in humoral and cellular immune responses over time upon SAR1S-CoV-2 vaccination may cause a lack of protective immunity. We conducted a longitudinal analysis of antibodies, T cells, and monocytes in 25 participants vaccinated with mRNA or ChAdOx1-S up to 12 weeks after the 3rd (boost...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Özbay Kurt, Feyza Gül (VerfasserIn) , Lepper, Alisa (VerfasserIn) , Gerhards, Catharina (VerfasserIn) , Römer, Mathis (VerfasserIn) , Lasser, Samantha (VerfasserIn) , Arkhypov, Ihor (VerfasserIn) , Bitsch, Rebekka (VerfasserIn) , Bugert, Peter (VerfasserIn) , Altevogt, Peter (VerfasserIn) , Gouttefangeas, Cécile (VerfasserIn) , Neumaier, Michael (VerfasserIn) , Utikal, Jochen (VerfasserIn) , Umansky, Viktor (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 October 2022
In: Frontiers in immunology
Year: 2022, Jahrgang: 13, Pages: 1-13
ISSN:1664-3224
DOI:10.3389/fimmu.2022.1012526
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fimmu.2022.1012526
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1012526
Volltext
Verfasserangaben:Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Ihor Arkhypov, Rebekka Bitsch, Peter Bugert, Peter Altevogt, Cécile Gouttefangeas, Michael Neumaier, Jochen Utikal and Viktor Umansky

MARC

LEADER 00000caa a2200000 c 4500
001 1856128849
003 DE-627
005 20240307085045.0
007 cr uuu---uuuuu
008 230814s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fimmu.2022.1012526  |2 doi 
035 |a (DE-627)1856128849 
035 |a (DE-599)KXP1856128849 
035 |a (OCoLC)1425217061 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Özbay Kurt, Feyza Gül  |d 1992-  |e VerfasserIn  |0 (DE-588)1284914275  |0 (DE-627)1840611251  |4 aut 
245 1 0 |a Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2  |c Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Ihor Arkhypov, Rebekka Bitsch, Peter Bugert, Peter Altevogt, Cécile Gouttefangeas, Michael Neumaier, Jochen Utikal and Viktor Umansky 
264 1 |c 12 October 2022 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.08.2023 
520 |a A gradual decay in humoral and cellular immune responses over time upon SAR1S-CoV-2 vaccination may cause a lack of protective immunity. We conducted a longitudinal analysis of antibodies, T cells, and monocytes in 25 participants vaccinated with mRNA or ChAdOx1-S up to 12 weeks after the 3rd (booster) dose with mRNA vaccine. We observed a substantial increase in antibodies and CD8 T cells specific for the spike protein of SARS-CoV-2 after vaccination. Moreover, vaccination induced activated T cells expressing CD69, CD137 and producing IFN-γ and TNF-α. Virus-specific CD8 T cells showed predominantly memory phenotype. Although the level of antibodies and frequency of virus-specific T cells reduced 4-6 months after the 2nd dose, they were augmented after the 3rd dose followed by a decrease later. Importantly, T cells generated after the 3rd vaccination were also reactive against Omicron variant, indicated by a similar level of IFN-γ production after stimulation with Omicron peptides. Breakthrough infection in participants vaccinated with two doses induced more SARS-CoV-2-specific T cells than the booster vaccination. We found an upregulation of PD-L1 expression on monocytes but no accumulation of myeloid cells with MDSC-like immunosuppressive phenotype after the vaccination. Our results indicate that the 3rd vaccination fosters antibody and T cell immune response independently from vaccine type used for the first two injections. However, such immune response is attenuated over time, suggesting thereby the need for further vaccinations. 
700 1 |a Lepper, Alisa  |d 1998-  |e VerfasserIn  |0 (DE-588)1299246060  |0 (DE-627)1856129756  |4 aut 
700 1 |a Gerhards, Catharina  |d 1992-  |e VerfasserIn  |0 (DE-588)1226262503  |0 (DE-627)1747234710  |4 aut 
700 1 |a Römer, Mathis  |e VerfasserIn  |0 (DE-588)1299246281  |0 (DE-627)1856130290  |4 aut 
700 1 |a Lasser, Samantha  |d 1990-  |e VerfasserIn  |0 (DE-588)1227276850  |0 (DE-627)174833753X  |4 aut 
700 1 |a Arkhypov, Ihor  |d 1995-  |e VerfasserIn  |0 (DE-588)122727694X  |0 (DE-627)1748337882  |4 aut 
700 1 |a Bitsch, Rebekka  |d 1991-  |e VerfasserIn  |0 (DE-588)1163544582  |0 (DE-627)1027872069  |0 (DE-576)508043565  |4 aut 
700 1 |a Bugert, Peter  |d 1964-  |e VerfasserIn  |0 (DE-588)1025332342  |0 (DE-627)722074018  |0 (DE-576)370212169  |4 aut 
700 1 |a Altevogt, Peter  |d 1947-  |e VerfasserIn  |0 (DE-588)1113206306  |0 (DE-627)867118784  |0 (DE-576)164729240  |4 aut 
700 1 |a Gouttefangeas, Cécile  |e VerfasserIn  |4 aut 
700 1 |a Neumaier, Michael  |d 1958-  |e VerfasserIn  |0 (DE-588)1028284934  |0 (DE-627)730532623  |0 (DE-576)375780580  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
700 1 |a Umansky, Viktor  |d 1955-  |e VerfasserIn  |0 (DE-588)102885756X  |0 (DE-627)731733207  |0 (DE-576)376300078  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in immunology  |d Lausanne : Frontiers Media, 2010  |g 13(2022) vom: Okt., Artikel-ID 1012526, Seite 1-13  |h Online-Ressource  |w (DE-627)657998354  |w (DE-600)2606827-8  |w (DE-576)343624834  |x 1664-3224  |7 nnas  |a Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 
773 1 8 |g volume:13  |g year:2022  |g month:10  |g elocationid:1012526  |g pages:1-13  |g extent:13  |a Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 
856 4 0 |u https://doi.org/10.3389/fimmu.2022.1012526  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fimmu.2022.1012526  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230814 
993 |a Article 
994 |a 2022 
998 |g 102885756X  |a Umansky, Viktor  |m 102885756X:Umansky, Viktor  |d 60000  |d 61900  |d 140000  |e 60000PU102885756X  |e 61900PU102885756X  |e 140000PU102885756X  |k 0/60000/  |k 1/60000/61900/  |k 0/140000/  |p 13  |y j 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 12 
998 |g 1028284934  |a Neumaier, Michael  |m 1028284934:Neumaier, Michael  |d 60000  |d 63300  |e 60000PN1028284934  |e 63300PN1028284934  |k 0/60000/  |k 1/60000/63300/  |p 11 
998 |g 1113206306  |a Altevogt, Peter  |m 1113206306:Altevogt, Peter  |d 60000  |d 61900  |d 50000  |e 60000PA1113206306  |e 61900PA1113206306  |e 50000PA1113206306  |k 0/60000/  |k 1/60000/61900/  |k 0/50000/  |p 9 
998 |g 1025332342  |a Bugert, Peter  |m 1025332342:Bugert, Peter  |d 60000  |d 63500  |e 60000PB1025332342  |e 63500PB1025332342  |k 0/60000/  |k 1/60000/63500/  |p 8 
998 |g 1163544582  |a Bitsch, Rebekka  |m 1163544582:Bitsch, Rebekka  |d 60000  |d 61900  |e 60000PB1163544582  |e 61900PB1163544582  |k 0/60000/  |k 1/60000/61900/  |p 7 
998 |g 122727694X  |a Arkhypov, Ihor  |m 122727694X:Arkhypov, Ihor  |d 60000  |d 61900  |e 60000PA122727694X  |e 61900PA122727694X  |k 0/60000/  |k 1/60000/61900/  |p 6 
998 |g 1227276850  |a Lasser, Samantha  |m 1227276850:Lasser, Samantha  |d 60000  |d 61900  |e 60000PL1227276850  |e 61900PL1227276850  |k 0/60000/  |k 1/60000/61900/  |p 5 
998 |g 1299246281  |a Römer, Mathis  |m 1299246281:Römer, Mathis  |d 60000  |d 63300  |e 60000PR1299246281  |e 63300PR1299246281  |k 0/60000/  |k 1/60000/63300/  |p 4 
998 |g 1226262503  |a Gerhards, Catharina  |m 1226262503:Gerhards, Catharina  |d 60000  |d 63300  |e 60000PG1226262503  |e 63300PG1226262503  |k 0/60000/  |k 1/60000/63300/  |p 3 
998 |g 1299246060  |a Lepper, Alisa  |m 1299246060:Lepper, Alisa  |d 60000  |e 60000PL1299246060  |k 0/60000/  |p 2 
998 |g 1284914275  |a Özbay Kurt, Feyza Gül  |m 1284914275:Özbay Kurt, Feyza Gül  |d 140000  |e 140000PO1284914275  |k 0/140000/  |p 1  |x j 
999 |a KXP-PPN1856128849  |e 4365949306 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1856128849"],"doi":["10.3389/fimmu.2022.1012526"]},"person":[{"family":"Özbay Kurt","role":"aut","display":"Özbay Kurt, Feyza Gül","given":"Feyza Gül"},{"family":"Lepper","display":"Lepper, Alisa","role":"aut","given":"Alisa"},{"family":"Gerhards","role":"aut","display":"Gerhards, Catharina","given":"Catharina"},{"family":"Römer","display":"Römer, Mathis","role":"aut","given":"Mathis"},{"given":"Samantha","family":"Lasser","role":"aut","display":"Lasser, Samantha"},{"family":"Arkhypov","role":"aut","display":"Arkhypov, Ihor","given":"Ihor"},{"display":"Bitsch, Rebekka","role":"aut","family":"Bitsch","given":"Rebekka"},{"given":"Peter","display":"Bugert, Peter","role":"aut","family":"Bugert"},{"role":"aut","display":"Altevogt, Peter","family":"Altevogt","given":"Peter"},{"display":"Gouttefangeas, Cécile","role":"aut","family":"Gouttefangeas","given":"Cécile"},{"given":"Michael","display":"Neumaier, Michael","role":"aut","family":"Neumaier"},{"given":"Jochen","family":"Utikal","role":"aut","display":"Utikal, Jochen"},{"given":"Viktor","role":"aut","display":"Umansky, Viktor","family":"Umansky"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"12 October 2022"}],"title":[{"title":"Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2","title_sort":"Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2"}],"name":{"displayForm":["Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Ihor Arkhypov, Rebekka Bitsch, Peter Bugert, Peter Altevogt, Cécile Gouttefangeas, Michael Neumaier, Jochen Utikal and Viktor Umansky"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"13 S."}],"recId":"1856128849","relHost":[{"language":["eng"],"pubHistory":["1.2010 -"],"disp":"Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2Frontiers in immunology","title":[{"title":"Frontiers in immunology","title_sort":"Frontiers in immunology"}],"part":{"year":"2022","text":"13(2022) vom: Okt., Artikel-ID 1012526, Seite 1-13","extent":"13","pages":"1-13","volume":"13"},"id":{"zdb":["2606827-8"],"eki":["657998354"],"issn":["1664-3224"]},"origin":[{"publisher":"Frontiers Media","publisherPlace":"Lausanne","dateIssuedKey":"2010","dateIssuedDisp":"2010-"}],"note":["Gesehen am 07.11.13"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"657998354","type":{"bibl":"periodical","media":"Online-Ressource"}}],"language":["eng"],"note":["Gesehen am 14.08.2023"]} 
SRT |a OEZBAYKURTBOOSTERDOS1220